Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
about
MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumorsThe challenge of developmental therapeutics for adrenocortical carcinomaInsulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma.Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.Childhood adrenocortical tumours: a review.Adrenal incidentaloma: a case of carcinoma.Percutaneous ablation of adrenal tumors.Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.Operative management for recurrent and metastatic adrenocortical carcinoma.p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cellsDeficits in the management of patients with adrenocortical carcinoma in Germany.Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.Current and emerging therapies for advanced adrenocortical carcinoma.Towards an understanding of the role of p53 in adrenocortical carcinogenesis.Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.A comprehensive approach to adrenal incidentalomas.Virilizing adrenocortical carcinoma in a child: A rare enigma.Current and emerging therapeutic options in adrenocortical cancer treatment.Adrenocortical tumorigenesis.Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases.Adrenal incidentalomas: presentation and clinical work-up.A rare coexistence of non-functional adrenocortical carcinoma and multicentric papillary thyroid microcarcinoma: a case report.Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.Primary hyperaldostronisim as initial presentation of adrenal cortical carcinoma with liver metastasis: a case reportOral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren): A case report.The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.Adrenocortical carcinoma: a clinician's update.Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?Clinical and imaging overview of functional adrenal neoplasms.Adrenocortical carcinoma: past, present, and future.Systemic therapy for advanced adrenal cancer.Adrenal tumours are more predominant in females regardless of their histological subtype: a review.Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.Acanthosis nigricans associated with an adrenocortical tumor in a pediatric patient.Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex.Challenges in surgical pathology of adrenocortical tumours.Mutational analysis of StAR gene in adrenal tumors.Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.
P2860
Q27027738-975B0CAE-BEF5-4D08-B19E-19BD93721DF0Q28072970-D5BABD87-3B2C-49F1-BEE1-234A504FFA9FQ33405908-41ED4335-EBFE-4F10-BDAB-9EEA591F5855Q33680565-BDC687A6-9500-4019-B0E0-D2A6B83412F2Q33722503-CE1411D4-0965-48A6-81CE-0B1DB09781FDQ33787124-3E50FA07-65AE-4136-9AE5-C74C1B40F910Q33914797-334FF091-A616-471E-AA37-C7E15D36B93EQ34027900-83480FE2-CF32-44D0-B01C-002F18342EFFQ34061022-D6B246AB-8DAB-4EB1-8628-94AD3E2DB5BEQ34428159-18683F52-7C8C-4827-ACCC-B2836A37D073Q34495638-67A57A24-40A8-4AA1-8227-6E9A5AB756EEQ34519879-9596F439-6268-478A-A3BC-A97B0C5E8EADQ35002304-0B071D2A-A3CA-4CE1-8211-C1E5F8B550A0Q35584305-077F15F0-AB7C-4BB9-A545-3EB07D4C770FQ35783751-22AF140F-039A-4924-8555-02F5B30B2305Q35896015-8A7C3FE6-DB00-48B1-BF46-0D748CCD153AQ36068304-4795EBBC-ACB1-4C67-8938-1A6E38C065DAQ36107823-C52EAD1F-23DC-4176-9B25-78366662850DQ36183873-A69CB064-88D9-41A2-8701-1F0792C0BDBFQ36694025-E75704E0-CB6C-495C-8B02-B0E69C3EF16FQ36743940-009400B7-9184-4814-895C-9FEE4CB969F3Q37050125-AF1469C3-8AB1-43E1-AA39-DC52AA5BF203Q37113715-8C8934C2-A9D4-4E2E-B4D9-6A5D3416F861Q37352749-82B1BB18-6CF6-4529-A683-5306FF21C677Q37552702-F594B282-5F93-45F6-8C20-A81E45EBE75FQ37606312-43C51BD7-B0D1-4317-A44C-EBC552E490DFQ37681171-FF70C626-C7E7-49C1-8E2D-BDDD707BB118Q37850996-5FF6BC48-BD14-4813-B2BB-E90152097C77Q37924953-499EFF3D-886A-480F-9454-1D2BA95A7477Q37998534-DA2B647C-55D7-4D8A-9F22-BDFACD15B9C0Q37999696-61E2AC15-204F-42EC-B3D1-F77FBAD5C9AEQ38001382-72F4629E-015C-4A66-A149-F6E960CDA221Q38072557-A0E73864-CDCD-40D6-9A14-8DFF7A776E57Q41474991-7837FF9A-6306-443C-B0AB-16A9238CAA4AQ42156904-DCD33CF2-3960-4114-B8C7-D0239500F000Q45271007-A3706B27-FBCC-474C-BE19-351899F1BF70Q46426593-BBE46A28-A912-4101-9788-5679D836DC56Q47576824-B6E00DB5-9111-41CD-B706-B4189CA2235CQ48325380-B11DACC6-6EAF-4ABD-A91F-969947E95F6DQ51980531-C169EFFB-6619-4834-B2A2-2FD4E7799D86
P2860
Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@ast
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@en
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@nl
type
label
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@ast
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@en
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@nl
prefLabel
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@ast
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@en
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@nl
P2860
P1433
P1476
Adrenal cortical carcinoma. Ep ...... nd a review of the literature.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N
P407
P577
1993-12-01T00:00:00Z